Study of the GSM with frequency of 950 MHz on the memory of male mice

Background and aims: The increasing use of productive machines with electromagnetic waves of different frequency and severity has led to perform many studies about the possible impact of the waves on the health of living creatures. The aim of this study was to investigate memory function and reminding in mice, exposed to microwave radiation with a frequency of 950 MHz (GSM signal). Methods: In this experimental study, 120 male mices were divided into 10 groups of 12 animals in each group. The exposed 9 groups were under microwave radiation at the power densities of 0.02, 1.3 and 8.6 mW/ cm2 and the time intervals of 2, 4 and 6 hours and one group was considered as control. The analysis of mice’s memory was done with the passive avoidance trial test and by measuring the frequency of animals entering the dark compartment of shuttle box and their entrance latency time in 6, 12, 24, 48 h, 1 and 2 weeks after the last learning stage. Results: The results showed no significant changes among the latency time of animals in entrance to the dark side of compartment, but the frequency of entrance showed significant difference among the exposure groups with the potent of 0, 0.02, 1.3 and 8.6 mW/cm2. Conclusion: Memory function and analysis of animals exposed to mobile radiation show a decrease depending on exposure time and power. The increasing frequency of animal in entrance to the dark field with the memory of electrical shock should be a sign of animal memory impairment with the exposure to the microwave mobile radiation

Comparison of the Effect of Two Kinds of Iranian Honey and Diphenhydramine on Nocturnal Cough and the Sleep Quality in Coughing Children and Their Parents

Coughing in a child induced by upper respiratory tract infections (URTIs) can be a problem, both for the child and its parents. Current studies show a lack of proven efficacy for over-the counter (OTC) medications, but promising data support the use of honey for children. The aim of this study was to compare the effects of two kinds of Iranian honey with diphenhydramine (DPH) on nocturnal pediatric coughs and the sleep quality of children and their parents. This was a clinical trial (registered in IRCT; No.: 28.20.7932, 15 October 2013). The study consisted of 87 patients. All the parents completed a standard previously validated questionnaire. The children were randomly assigned to one of three treatment groups: Group 1, Honey type 1 (Kimia Company, Iran) (n = 42), Group 2, Honey type 2 (Shahde-Golha, Iran) (n = 25), and Group 3, DPH (n = 20). Each group received double doses of the respective treatments on two successive nights. A second survey was then administered via a telephone interview in which the parents were asked the same questions. The mean scores for all aspects of coughs were significantly decreased in each group before and after the treatment. All three treatments improved the cough and sleep scores. Honey type 1 was superior to DPH in improving all aspects of coughs, except the frequency, and Honey type 2 was more effective than DPH in improving all aspects of coughs, except the sleep quality of the child. There was no significant difference between Honey type 1 and 2 in any aspects of cough relief in the present study. The results suggest that honey may provide better cough relief than DPH in children and improve the sleep quality of children and their parents

Comparison of the Effect of Two Kinds of Iranian Honey and Diphenhydramine on Nocturnal Cough and the Sleep Quality in Coughing Children and Their Parents

Coughing in a child induced by upper respiratory tract infections (URTIs) can be a problem, both for the child and its parents. Current studies show a lack of proven efficacy for over-the counter (OTC) medications, but promising data support the use of honey for children. The aim of this study was to compare the effects of two kinds of Iranian honey with diphenhydramine(DPH) on nocturnal pediatric coughs and the sleep quality of children and their parents. This was a clinical trial (registered in IRCT; No.: 28.20.7932, 15 October 2013). The study consisted of 87 patients. All the parents completed a standard previously validated questionnaire. The children were randomly assigned to one of three treatment groups: Group 1, Honey type 1 (Kimia Company, Iran) (n = 42), Group 2, Honey type 2 (Shahde-Golha, Iran)(n = 25), and Group 3, DPH (n = 20). Each group received double doses of the respective treatments on two successive nights. A second survey was then administered via a telephone interview in which the parents were asked the same questions. The mean scores for all aspects of coughs were significantly decreased in each group before and after the treatment. All three treatments improved the cough and sleep scores. Honey type 1 was superior to DPH in improving all aspects of coughs, except the frequency, and Honey type 2 was more effective than DPH in improving all aspects of coughs, except the sleep quality of the child. There was no significant difference between Honey type 1 and 2 in any aspects of cough relief in the present study. The results suggest that honey may provide better cough relief than DPH in children and improve the sleep quality of children and their parents

Comparison of the age-adjusted baseline scores of the three groups.

<p>Comparison of the age-adjusted baseline scores of the three groups.</p

Comparison of the scores before and after the intervention in the three groups.

<p>Comparison of the scores before and after the intervention in the three groups.</p

CONSORT flowchart of the study.

<p>CONSORT flowchart of the study.</p

Comparison of age-adjusted mean differences in the scores before and after the intervention in the three groups.

<p>Comparison of age-adjusted mean differences in the scores before and after the intervention in the three groups.</p

Nocturnal cough and sleep difficulty assessment questionnaire.

<p>Nocturnal cough and sleep difficulty assessment questionnaire.</p